An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD

Este estudio examinará la seguridad y la eficacia preliminar de los hongos con psilocibina para tratar a adultos con TEPT. Hasta 24 participantes formarán parte de este estudio. Cada participante ingerirá psilocibina de hongos secos en una formulación con chocolate.

Status

recruiting

Phase

Phase 1

Institution

Suzanne "Sue" Sisley MD

Start date

2026-02-09

End date

2026-03-01

Registry ID

NCT07275970

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.